WINTON GROUP Ltd cut its holdings in shares of Plexus Corp. (NASDAQ:PLXS – Free Report) by 56.4% during the second quarter, HoldingsChannel.com reports. The fund owned 2,913 shares of the technology company’s stock after selling 3,770 shares during the quarter. WINTON GROUP Ltd’s holdings in Plexus were worth $876,000 as of its most recent filing with the Securities and Exchange Commission.
Other institutional investors have also modified their holdings of the company. California State Teachers Retirement System increased its stake in Plexus by 29,890.4% in the second quarter. California State Teachers Retirement System now owns 9,414,880 shares of the technology company’s stock valued at $2,830,772,000 after purchasing an additional 9,383,487 shares during the period. BlackRock Inc. acquired a new stake in shares of Plexus during the second quarter worth about $1,311,631,000. Geode Capital Management LLC boosted its stake in shares of Plexus by 0.6% during the fourth quarter. Geode Capital Management LLC now owns 672,614 shares of the technology company’s stock worth $98,890,000 after buying an additional 4,054 shares during the period. Bank of America Corp DE acquired a new stake in shares of Plexus during the second quarter worth about $60,281,000. Finally, Bank of New York Mellon Corp purchased a new position in shares of Plexus during the second quarter worth about $55,525,000. 94.45% of the stock is owned by institutional investors and hedge funds.
Plexus Trading Down 6.2%
NASDAQ:PLXS opened at $239.63 on Tuesday. The company has a market capitalization of $6.41 billion, a PE ratio of 35.34 and a beta of 0.89. The company has a quick ratio of 0.72, a current ratio of 1.49 and a debt-to-equity ratio of 0.06. Plexus Corp. has a 52-week low of $132.03 and a 52-week high of $307.06. The stock has a fifty day simple moving average of $254.11 and a 200-day simple moving average of $247.67.
Analyst Upgrades and Downgrades
Several analysts have commented on the company. Needham & Company LLC reaffirmed a “buy” rating and set a $310.00 price objective on shares of Plexus in a research note on Friday, August 14th. Zacks Research upgraded Plexus from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, August 11th. Weiss Ratings lowered Plexus from a “buy (b-)” rating to a “hold (c+)” rating in a report on Wednesday, September 9th. Sidoti raised Plexus from a “neutral” rating to a “buy” rating and set a $308.00 target price on the stock in a report on Friday, July 31st. Finally, Stifel Nicolaus increased their price target on Plexus from $280.00 to $330.00 and gave the stock a “buy” rating in a report on Monday, June 22nd. One investment analyst has rated the stock with a Strong Buy rating, five have assigned a Buy rating and one has given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and a consensus target price of $273.00.
Get Our Latest Research Report on PLXS
Insider Transactions at Plexus
In other Plexus news, CEO Todd P. Kelsey sold 1,500 shares of Plexus stock in a transaction that occurred on Wednesday, August 19th. The shares were sold at an average price of $250.98, for a total value of $376,470.00. Following the completion of the sale, the chief executive officer directly owned 65,888 shares of the company’s stock, valued at approximately $16,536,570.24. The trade was a 2.23% decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Karen Rapp sold 500 shares of the stock in a transaction on Monday, August 31st. The stock was sold at an average price of $240.87, for a total value of $120,435.00. Following the transaction, the director directly owned 7,535 shares in the company, valued at approximately $1,814,955.45. This represents a 6.22% decrease in their position. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 7,500 shares of company stock worth $2,039,375 over the last ninety days. 1.78% of the stock is currently owned by corporate insiders.
Plexus Company Profile
Plexus Corp. is a global electronics manufacturing services company that designs, manufactures and services products for original equipment manufacturers. The company supports customers across the product life cycle, from product development and engineering to supply chain management, assembly, testing, fulfillment and aftermarket services.
Plexus provides solutions for industries including healthcare and life sciences, industrial and commercial, aerospace and defense, and communications.
Featured Stories
- Five stocks we like better than Plexus
- Analysts Are Punting Their Calls Into the Next Quarter After Adobe’s Mixed Earnings
- Institutional Money Is Pouring Into These 2 Altcoin ETFs
- The End of Big Tech Buybacks? Only One Hyperscaler Is Still Repurchasing Shares
- 3 Dividend Kings to Buy While They’re Still Beaten Down
Want to see what other hedge funds are holding PLXS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Plexus Corp. (NASDAQ:PLXS – Free Report).
Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.
